“…Of note however, cholinergic neurons are also integral in the development of amyloid-based pathology Francis et al, 1999;Tran et al, 2002) as they can regulate APP processing and, in turn, A can decrease ACh synthesis and release (Heinitz et al, 2006;Hoshi et al, 1996Hoshi et al, , 1997Kar et al, 1996Kar et al, , 1998Pederson et al, 1996;Pederson & Blusztajn, 1997;Satoh et al, 2001). The stimulation of either nicotinic or muscarinic ACh receptors on cholinoreceptive neurons can promote non-amyloidogenic APP cleavage, thereby potentially decreasing the production of toxic A (Isacson et al, 2002;Seo et al, 2001; www.intechopen.com al., 2002; Unger et al, 2005;Verhoeff, 2005). Thus, the activation of either 7-or 42-nicotinic receptors (Lahiri et al, 2002;Shimohama & Kihara, 2001;Zamani & Allen, 2001) can decrease A toxicity by protecting neurons through activation of PI3-kinase and increasing levels of Bcl-2 and Bcl-x50.…”